AI Revolutionizing Cell and Genetic Engineering: Innovations and Applications
- PMID: 40553335
- DOI: 10.1007/978-1-0716-4690-8_12
AI Revolutionizing Cell and Genetic Engineering: Innovations and Applications
Abstract
The integration of Artificial Intelligence (AI) into the realms of cell and genetic engineering has ushered in a transformative era of innovation and discovery. This chapter explores the myriad ways in which AI technologies are revolutionizing these fields, from data analysis and drug discovery to genomic sequencing and gene editing. AI algorithms are adept at analyzing vast datasets, uncovering intricate patterns, and predicting biological phenomena with unparalleled accuracy. In drug discovery, AI-driven platforms expedite the identification of potential therapeutics by simulating molecular interactions and predicting their efficacy. Genomic sequencing efforts benefit from AI's ability to interpret genetic variations and their implications for health and disease. Furthermore, AI-guided gene editing techniques, such as CRISPR-Cas9, enable precise and targeted modifications of the genome. Beyond the laboratory, AI facilitates personalized medicine by analyzing genetic data to tailor treatments to individual patients. This chapter underscores the pivotal role of AI in advancing cell and genetic engineering, promising a future of unprecedented scientific breakthroughs and personalized healthcare solutions.
Keywords: Artificial intelligence (AI); Cell engineering; Data analysis; Drug discovery; Gene editing; Genetic engineering; Genomic sequencing; Precision medicine.
© 2025. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Alvarez J, Guan Y (2022) AI-powered genomic analysis and its impact on personalized medicine. Trends Biotechnol 40(5):563–578
-
- Cohen A, Zhang Z (2022) Enhancing single-cell RNA sequencing with AI: applications and challenges. Cell Syst 13(4):364–374
-
- Davis A, Patel P (2021) Organ-on-a-chip systems enhanced by AI: implications for drug development and personalized medicine. Adv Drug Deliv Rev 175:113835
-
- Harris T, O’Neill C (2023) Ethical and regulatory considerations for AI in genetic engineering. Bioethics 37(2):157–168
MeSH terms
LinkOut - more resources
Full Text Sources
